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Aseptic Raman spectroscopy can detect changes
associated with the culture of human dental pulp
stromal cells in osteoinductive culture
Adam Mitchell,a Lorna Ashton,b Xuebin B. Yang,a Royston Goodacre,c
Matthew J. Tomlinson,a Alistair Smithd and Jennifer Kirkham*a
There is an unmet need for the non-invasive characterisation of stem cells to facilitate the translation of
cell-based therapies. Raman spectroscopy has proven utility in stem cell characterisation but as yet no
method has been reported capable of taking repeated Raman measurements of living cells aseptically
over time. The aim of this study was to determine if Raman spectroscopy could be used to monitor
changes in a well characterised cell population (human dental pulp stromal cells (DPSCs)) by taking
repeated Raman measurements from the same cell populations in osteoinductive culture over time and
under aseptic conditions. DPSCs were isolated from extracted premolar teeth from 3 consenting donors.
Following in vitro expansion, DPSCs were maintained for 28 days in osteo-inductive medium. Raman
spectra were acquired from the cells at days 0, 3, 7, 10, 14 and 28. Principal component analysis (PCA) was
carried out to assess if there was any temporal spectral variation. At day 28, osteoinduction was
conﬁrmed using alizarin red staining and qRT-PCR for alkaline phosphatase and osteocalcin. Alizarin red
staining was positive in all samples at day 28 and signiﬁcant increases in alkaline phosphatase (p < 0.001)
and osteocalcin (p < 0.05) gene expression were also observed compared with day 0. PCA of the Raman
data demonstrated trends in PC1 from days 0–10, inﬂuenced by protein associated features and PC2 from
days 10–28, inﬂuenced by DNA/RNA associated features. We conclude that spectroscopy can be used to
monitor changes in Raman signature with time associated with the osteoinduction of DPSCs using
repeated measurements via an aseptic methodology.
Introduction
The field of tissue engineering and regenerative medicine has
advanced rapidly since its inception by Langer and Vacanti in
1993,1 with clinical trials for the treatment of numerous con-
ditions underway.2 Stem cells are an important component of
the tissue engineering toolkit, from pluripotent embryonic
stem cells and induced pluripotent stem cells to multipotent
somatic stem cells including mesenchymal stem cells (MSCs)
and haematopoietic stem cells (HSCs). The use of MSCs avoids
the ethical concerns associated with embryonic stem cell
research and whilst MSCs cannot diﬀerentiate along as
many cell lineages they still possess demonstrable capacity for
diﬀerentiation into osteoblasts, chondrocytes, adipocytes,3
tenocytes,4 hepatocytes5 and neural cells.6 Such directed diﬀeren-
tiation of MSCs and validation of their resulting phenotype
requires significant expansion of stem cell cultures and testing
with invasive and/or destructive methods that preclude their
subsequent use in clinical applications. Non-invasive methods
that can reliably monitor stem cell diﬀerentiation could reduce
the need for in vitro expansion and save researchers a great
deal of time and resources when conducting their experi-
ments. Raman spectroscopy is one such potential methodo-
logy for in situ analysis.
Raman spectroscopy has the capacity to be both non-inva-
sive and non-destructive and utilises a monochromatic light
source to determine sample chemistry. Upon interaction with
the sample a small fraction of the light, approximately 1 in 106
to 108 photons,7 is shifted in wavelength with respect to the
incident laser. Many chemical bonds in the sample cause
unique Raman shifts such that the resultant spectrum can
be considered to be a ‘molecular fingerprint’ that is unique
to the sample under analysis. Several recent publications
have described the use of Raman spectroscopy to determine cell
viability,8–10 to identify general markers of cell diﬀerentiation,9,11
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to track diﬀerentiation to an osteoblastic phenotype12
and to elucidate changes in extracellular matrix calcifica-
tion and/or mineralisation concomitant with osteoblastic
diﬀerentiation.13–16 These studies have identified a signature
profile for the diﬀerentiation of stem cells down the osteogenic
lineage based on the emergence and relative ratios of peaks in
their Raman spectra illustrated in Fig. 1. Whilst these data
have highlighted the potential usefulness of Raman spectro-
scopy in stem cell phenotyping, to date repeated measure-
ments of the same cell population in long term culture have
been precluded due to the need to maintain sterility, yet the
ability to deliver this would be greatly advantageous when
developing cell-based regenerative therapies. Raman scattering
eﬃciency is very poor and the distance between the sample
and the microscope objective needs to be as small as possible
for maximum sensitivity. In order to maximise the potential of
Raman spectroscopy as a tool for non-invasive stem cell
characterisation over time, studies need to be conducted
under aseptic conditions while maintaining the strength of
the Raman signal. This would then ultimately permit early/pre-
dictive identification of diﬀerentiation such that stem cells
may be used in further downstream applications.
In this study, our aim was to develop a novel methodology
that permits the repeated acquisition of Raman spectra from
the same cell cultures without prejudicing culture sterility,
including investigating whether or not the Raman acquisition
process might adversely aﬀect the cells’ behaviour. Our
hypothesis was that Raman might usefully indicate early
phenotypic shifts in a mixed stromal cell population during
osteoinduction. We elected to use dental pulp stromal cells
(DPSCs) for this work as their diﬀerentiation behaviour is well
characterised and documented within the literature. DPSCs
are one of several cell sources that are more broadly classed as
MSCs and were first isolated by Gronthos et al. (2000).17 They
have since been shown to diﬀerentiate down multiple lineages
including osteogenic, dentinogenic, adipogenic, chondrogenic,
myogenic and neurogenic and express many of the cell surface
markers used to characterise bone marrow derived MSCs.18–22
However, it should be noted that the propensity for diﬀeren-
tiation along a specific lineage can vary amongst MSCs derived
from diﬀerent sources.21,23 DPSCs were chosen specifically for
this study as they have a proven predisposition toward the
osteogenic/dentinogenic lineage,24 presenting a reliable and
well documented sample for evaluating our new method. We
envisage that Raman spectroscopy would be used as part of a
minimally invasive approach to tissue engineering and as such
we used unsorted stromal cells from the dental pulp as
opposed to a fluorescence activated cell-sorted (FACS) enriched
stem cell population. We osteoinduced DPSCs and acquired
Raman spectra at regular time intervals throughout osteo-
induction culture period to determine both technical feasibility
and identify whether changes in the Raman spectra might be
prejudicial to the well documented diﬀerentiation of DPSCs
under these conditions.
Materials and methods
Raman spectroscopy of dental pulp stromal cells (DPSCs) in
osteogenic culture
DPSC isolation and culture. Human molars were obtained
from one male and two female donors, aged 9, 22 and 35 year,
by informed written consent (in the case of minors, consent
was obtained through the parent/guardian) through the Leeds
School of Dentistry Research Tissue Bank as authorised by the
Dental Research Ethics Committee (DREC 07/H1306/93+5).
DPSCs were isolated by the collagenase/dispase digestion
method previously described by Gronthos et al.17 and main-
tained in basal medium, α-MEM containing 10% foetal calf
serum (FCS) (Biosera, Ringmer, UK), 1% 10 000 units per
10 mg mL−1 penicillin/streptomycin solution (Sigma-Aldrich,
Gillingham, UK) and 1% 200 mM L-glutamine (Sigma-Aldrich).
Cultures were incubated at 37 °C, 5% CO2 and routinely
passaged. DPSCs at passage 3 were used in all subsequent
experiments.
DPSC phenotyping. DPSCs were treated with 0.25% trypsin/
0.02% EDTA (Sigma-Aldrich) and centrifuged to generate a cell
pellet. Cells were labelled with 10 µL FcR blocking solution
(Miltenyi Biotec, Bergisch Gladbach, Germany) and various
antibodies (see below, 10 µL per 1 × 106 cells unless stated) in
a total volume of 100 µL labelling buﬀer (PBS, 2 mM EDTA
(Alfa Aesar, Heysham, UK) and 0.5% (w/v) BSA (Sigma-
Aldrich)) for 20 minutes at room temperature in the dark. Fol-
lowing labelling, 900 µL labelling buﬀer was added to each
sample before centrifugation and resuspension in 500 µL
labelling buﬀer. Samples were then analysed using an LSRII flow
cytometer (BD Biosciences, San Jose, CA) running FACSDiva
8.0 software (BD Biosciences), subsequent data analysis was
Fig. 1 Proposed timeline of events outlining the osteogenic diﬀeren-
tiation process of stem cells using Raman spectroscopy, based on data
from ref. 9 and 11–15.
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performed using Kaluza 1.3 (Beckman Coulter, Inc., Miami,
FL). Antibodies used were: CD29-Alexa Fluor 488 (5 µL per 1 ×
106 cells), CD34-FITC (5 µL per 1 × 106 cells), CD44-FITC,
CD73-PE (2 µL per 1 × 106 cells), CD90-APC and CD166-PE (all
Biolegend, San Diego, CA). All threshold values were obtained
by analysing autofluorescence of non-labelled hDPSCs and
reactivity of isotype matched controls. Events were gated based
on forward and side scatter and colour compensation was
performed.
Quartz customised flask preparation. Customised cell
culture flasks with quartz windows (Fig. 2), suitable for Raman
spectroscopy, were prepared by drilling 1 cm diameter holes in
25 cm2 cell culture flasks. Flasks were washed several times
with sterile pure water to remove debris and finally sterilised
with 70% ethanol. Heat sterilised quartz discs (Global Optics,
Bournemouth, UK), 14 mm diameter × 0.15 mm thickness,
were glued to the outside of the flasks using a UV cured
methacrylate glue (Loctite, Hempstead, UK) and cured for
5 min under UV light. To ensure complete sterilisation, flasks
were placed under a UV lamp for a further 90 min and periodi-
cally rotated to ensure penetration to all surfaces.
DPSC sample preparation and Raman spectroscopy. Sterile
poly-L-lysine (0.1 mg mL−1, molecular weight, 70 000–150 000
(Sigma-Aldrich)) was used to coat the quartz surface of the
customised flasks to enhance cell adhesion, as poly-L-lysine
coatings have little/no eﬀect on Raman spectra.25 The solution
was then aspirated and the flask dried in an incubator at 37 °C
overnight. DPSCs suspended in basal medium were pipetted
directly on to the quartz surface at 1 × 105 cells per cm2 (n = 3)
and incubated overnight at 37 °C to adhere. The following day
flasks were topped up with osteoinductive medium, (basal
medium supplemented with 0.25 mM ascorbic acid, 10 mM
β-glycerophosphate and 100 nM dexamethasone (all Sigma-
Aldrich)). This was designated day 0. Each of the donor
samples were cultured and analysed in triplicate. An equal
number of samples were maintained in osteogenic conditions
but did not undergo Raman analysis. These were used as con-
trols for the sampling process. At no point during the cell
culture period was there any evidence of bacterial or fungal
contamination.
Prior to Raman analysis the cell culture medium was aspi-
rated and flasks filled with Hanks balanced salt solution
(HBSS) with glucose added to a final level of 0.45%. Flasks
were placed on the stage of a Leica DMLM microscope
attached to a Renishaw RM series Raman spectrometer and
inverted toward the objective. A 40×/0.8 NA water immersion
objective was immersed in a small drop of HBSS placed on the
quartz surface. DPSCs were first brought into focus under
transmitted white light then over-focused by 5 µm and
switched to 785 nm light for spectrum acquisition. Spectra
were acquired at days 0, 3, 7, 10, 14 and 28. At each time point
15 spectra were acquired over the wavenumber range
600–1800 cm−1 with an exposure time of 120 s and the power
on the sample from the 785 nm laser was 66 mW. With
9 samples (three donors in triplicate) this produced a total of
135 spectra at each time point. All spectra were acquired from
the DPSC monolayer even at later time points, despite the
emergence of mineralised nodules, for consistency. Cell free
sections of quartz were used to acquire the background spec-
trum. Following analysis the HBSS was aspirated and replaced
with osteoinductive medium and the flasks returned to the
incubator.
Data analysis. Pre-processing of spectra was performed in
Grams/32 (Thermo Scientific, Waltham, USA) with further pro-
cessing and validation by principal component analysis (PCA)
performed in Matlab version R2013b. In Grams each indivi-
dual spectrum was background subtracted using cell free areas
of HBSS filled quartz customised flasks, y-axis normalised to
the peak at 1003 cm−1 to correct for any minor unavoidable
instrumental drift due to sampling over a long period of time,
and smoothed using a 7 point Savitzky-Golay filter. All spectra
were then exported to Microsoft Excel for further processing in
Matlab. PCA was performed on all spectra from each individual
donor and used to remove outlying spectra from each time
point. The data were then averaged using one spectrum from
each donor per time point. Finally second derivative spectra
were calculated and further smoothing performed. PCA was
then carried out to visualise the fully processed data. Such pre-
processing was required to overcome intrinsic experimental
constraints such as the longer working distance and the need
to acquire spectra through an interface presented by working
aseptically with quartz windowed flasks.
Osteogenic and cell stress marker gene expression of DPSCs ±
analysis by Raman spectroscopy determined by qRT-PCR
To confirm osteoinduction and determine any eﬀects of
Raman spectroscopy on the osteoinductive process, qRT-PCR
was used to determine marker gene expression, RNA isolation
and reverse transcription was performed on DPSCs following
osteoinductive culture ± Raman spectroscopy analysis. Briefly,
DPSCs were lysed by incubation with Trizol® (Invitrogen,
Paisley, UK) for 20 min at room temperature. RNA was
extracted from cell lysates using an RNeasy mini kit with
additional DNase digestion (Qiagen, Crawley, UK) following
the manufacturers recommendations. RNA concentrations
were quantified using a NanoDrop spectrophotometer
Fig. 2 Schematic of a quartz window customised ﬂask prepared for
Raman spectroscopy. The microscope used to acquire Raman spectra
uses an upright turret, therefore ﬂasks had to be inverted toward the
microscope objective. This necessitated the ﬁlling of the ﬂask with HBSS
to prevent the cells from desiccating during analysis.
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(Thermo Scientific). A High Capacity RNA-to-cDNA Kit
(Applied Biosystems, Carlsbad, USA) was used to prepare 200
ng of cDNA in 20 µL reaction volumes as per the manufac-
turer’s instructions. Reactions were run on a MJ Research
PTC-100 Thermo Cycler, at 37 °C for 1 h and 95 °C for 5 min.
qRT-PCR was performed using TaqMan gene expression assays
(Applied Biosystems) for alkaline phosphatase (ALP) and osteo-
calcin (OC): assay numbers Hs01029144-m1 and Hs00609452-
g1 respectively, to determine early and late osteogenic marker
expression and for heat shock transcription factor 1 (HSF1),
hypoxia inducible factor 1 (HIF1A) and lactate dehydrogenase
(LDH): assay numbers Hs00232134-m1, Hs00153153-m1 and
Hs00929956-m1 respectively, to investigate cell stress marker
expression. Reactions were carried out in 96 well plates on a
Roche LightCycler® 480 system. Optimal cDNA concentration
was determined to be 5 ng/reaction by plotting standard
curves with known cDNA concentrations. Data were normal-
ised to YWHAZ assay number Hs00237047-m1, and analysed
using the comparative cycle threshold method (ΔCT). YWHAZ
was selected as it has been shown to be a far more reliable
housekeeping gene compared with some of the more tra-
ditional housekeeping genes such as GAPDH and ACTB.26
Three patient samples, one in duplicate, were analysed using
both DPSCs that had undergone analysis by Raman spectro-
scopy and DPSCs cultured in parallel under the same con-
ditions but without subjection to Raman spectroscopy after 28
days of osteoinductive culture. Samples were analysed in tripli-
cate for a total n = 12 for each group. Samples from day 0 were
used to provide a baseline. Graphs of the mean ΔCT ± SE
were plotted in Microsoft Excel and statistical significance
was determined by one-way ANOVA using GraphPad Instat 3
software.
Extracellular matrix calcification of DPSC cultures ± analysis
by Raman spectroscopy using alizarin red staining
Alizarin red staining was performed on day 28 DPSC cultures
that had been analysed by Raman spectroscopy and those that
had not (n = 2). In both cases, DPSCs had been cultured in
osteoinductive medium as described above. Cell monolayers
were washed twice with PBS and fixed in 10% neutral buﬀered
formalin for 1 h at room temperature. Cell monolayers were
incubated with 1% Alizarin red solution (Sigma-Aldrich) (pH
4.2), for 20 min at room temperature. The Alizarin red solution
was then removed and excess stain washed away with repeated
washes with de-ionised water. Cultures were then imaged
using an Olympus BX50 microscope with accompanying Nikon
DS-Fi1 camera.
Results and discussion
Phenotyping of undiﬀerentiated DPSCs using flow cytometry
Analysis of DPSCs confirmed these cells possessed a stromal
phenotype, being positive for the standard DPSC markers
tested (including CD29, CD44, CD73, CD90, CD166) and nega-
tive for the haematopoietic marker CD34 (Fig. 3).
Raman spectroscopy of DPSCs osteogenic culture
Raman spectroscopy has previously been used to demonstrate
late stage osteogenic diﬀerentiation of stem cells by analysing
putative mineralised nodules in the extracellular matrix.13,15 In
this study DPSCs were repeatedly analysed by Raman spec-
troscopy with a focus on earlier time points i.e. prior to the
emergence of mineralised nodules. Fig. 4 depicts the average
spectra for each time point (day 0 to day 28) following subtrac-
tion of the signal from the (quartz) background. Many peaks
typical of biological samples were clearly evident such as
phenylalanine at 1003 cm−1, CH3, CH2 found in collagen at
1453 cm−1 and amide I at 1660 cm−1.
Principal component analysis (PCA) was performed on
spectra obtained from DPSCs from three donor samples, ana-
lysed in triplicate, which had been averaged, n = 135 spectra at
Fig. 3 Representative histograms showing cell surface marker expression
by DPSCs. Markers examined were CD29, CD44, CD73, CD90, CD166
and CD34. Data conﬁrm the stromal phenotype of these cells as they
were negative for the haematopoietic marker CD34 and positive for all
the other markers tested (red histogram cells, black histogram isotype
controls).
Fig. 4 Average background subtracted spectra of osteo-induced
DPSCs at days 0, 3, 7, 10, 14 and 28, n = 135 spectra per time point. Data
from three separate donors examined in triplicate.
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each time point. PCA is a method of reducing the dimensional-
ity of multivariate data into groups of potentially correlated
variables called principal components (PCs). PC1 represents
the group of variables responsible for the greatest amount of
variation in the data and PC2 the group of variables respon-
sible for the second greatest variation in the data and so on. In
the case of Raman spectra such as those presented here the
variables are the wavenumbers which in turn correspond to par-
ticular molecular species within the cells. Fig. 5A is a 2D scatter
plot of PC1 and PC2 scores accounting for 54.2% and 12.4% of
the variation in the data set respectively, this indicates that the
wavenumbers contained within PC1 and concomitantly the
molecular species they are associated with accounted for
54.2% of the variation in the data set and so on. The PCA
scores plot demonstrated a clustering of spectra at each time
point, illustrating that the spectral collection was reproducible.
There was overlapping of spectra between adjacent time points
as might be expected if a continuous phenotypic shift was
occurring due to cell diﬀerentiation. Despite the overlapping
of time points a clear trend was observed from day 0 to day 10
along PC1 while a trend from day 7 to day 28 was observed
along PC2. Loadings plots can be drawn for each PC to illus-
trate those spectral features that are responsible for the vari-
ance in that PC. Peaks on the same side of a loading plot will
be behaving similarly, whilst peaks on opposite sides of a
loading plot will be behaving diﬀerently with respect to their
scores within a given PC. Fig. 5B + C illustrate the loading
plots for PC1 and PC2. The loading plot for PC1 showed posi-
tive peaks for wavenumbers corresponding to amide bonds
(1260 cm−1 and 1660 cm−1), CH3, CH2 from collagen
(1345 cm−1 and 1453 cm−1), phenylalanine (1003 cm−1) and
lipids (1126 cm−1) whilst wavenumbers corresponding to
ribose (975 cm−1 and 1020 cm−1), the nucleic acids guanine
and adenine (1420 cm−1) and DNA (1490 cm−1) had negative
peaks. Similarly the loading plot for PC2 had positive peaks at
1003 cm−1, 1453 cm−1 and 1660 cm1 with negative peaks at
975 cm−1, 1020 cm−1 and 1490 cm−1. Putative peak assign-
ments were based on Movasaghi et al.27 As the above indivi-
dual PCs both use the same areas it may be hard to diﬀerentiate
which are the important vibrations with respect to time, there-
fore PC1 was plotted against PC2 (Fig. 5D). Each data point
represents the loadings value of PCs 1 and 2 for a given wave-
number. When plotted as such the position of a given wave-
number on the plot when transposed on the original scores
plot indicates where that wavenumber varies most greatly. This
loadings plot showed that two protein associated peaks at
1453 cm−1 and 1660 cm−1 transpose along the trend in PC1
from days 0 to 10, whilst two DNA/RNA associated peaks
975 cm−1 and 1020 cm−1 transpose along the trend in PC2
from days 10 to 28 as did the phenylalanine peak at
1003 cm−1.
Finally, to confirm whether osteoinduction of DPSCs was
evident by day 28, several Raman spectra were acquired from
putative mineralised nodules, (Fig. 6). The well characterised
mineral associated region, 955 cm−1–964 cm−1, described in
several previous studies,13–15 was clearly evident.
Eﬀect of Raman spectroscopy on DPSC osteogenic marker
gene expression and extracellular matrix deposition
qRT-PCR and Alizarin red staining were used to confirm
osteoinduction of DPSCs after 28 days in osteoinductive
medium. Samples that had undergone Raman measurements,
and those grown in parallel without being subject to Raman,
were analysed to determine if the data acquisition process and
the Raman spectroscopy itself had any eﬀect on DPSC osteo-
genic diﬀerentiation. qRT-PCR showed significant increases in
ALP and OC expression between days 0 and 28 of osteo-
inductive culture irrespective of whether or not the DPSCs
had undergone Raman analysis (p < 0.001 and p < 0.05
Fig. 5 (A) Principal component analysis of the osteogenic diﬀeren-
tiation of DPSCs at days 0, 3, 7, 10, 14 and 28. 2D scatter plot for princi-
pal components 1 and 2. Each position displayed is the average of three
spectra, one from each donor, for every time point. There is a clear
trend in PC1 between days 0 and 10 and a further trend in PC2 between
days 0 and 10 and days 10 and 28, marked with arrows. (B + C) PCA
loadings plot for PC1 and PC2 respectively, from the PCA of DPSCs that
had been osteo-induced for 0, 3, 7, 10, 14 and 28 days. Signiﬁcant posi-
tive and negative peaks are marked. (D) PCA loadings plot for PC1 versus
PC2, the outer green circle indicates 95% conﬁdence. In the legend are
groups of wavenumbers from peaks that vary signiﬁcantly.
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respectively) (Fig. 7A). There was no significant diﬀerence in
the expression of either gene between DPSCs which had been
analysed by Raman spectroscopy and those that had not.
Alizarin red staining was used to demonstrate extracellular
matrix calcification in DPSC cultures after 28 days of osteo-
induction for samples that had been analysed by Raman
spectroscopy (Fig. 7B) and those that had not (Fig. 7C). Positive
Alizarin red staining was observed in all samples, with no
discernible diﬀerences between the Raman and non-Raman
groups. This was not quantified but the findings align with
the results of the Raman signature for hydroxyapatite that was
obtained from apparent mineralised nodules in the cultures.
Eﬀect of Raman spectroscopy on DPSC cell stress marker gene
expression
The data acquisition process during Raman spectroscopy used
in this study was entirely aseptic and non-invasive permitting
the same cell cultures to be analysed repeatedly throughout
the diﬀerentiation process. However, this method had the
potential to induce a cell stress response, due to, for example,
limited gas diﬀusion, exposure to ambient temperature and
atmospheric gas concentrations, as well as the laser on the
sample. In order to test for any cell stress response, the
expression of three marker genes, heat shock transcription
factor 1 (HSF), hypoxia inducible factor 1 (HIF) and lactate
dehydrogenase (LDH) was determined by qRT-PCR for DPSCs
at day 0 and day 28 ± Raman spectroscopy (Fig. 8). No signifi-
cant diﬀerences in the expression of all three genes were
observed between the groups (p > 0.05) showing that the
Raman and the new culturing approach had not aﬀected the
cells.
This study had two aims, to develop a method for the
aseptic repeated acquisition of Raman spectra from the same
cell cultures over a period of time that did not perturb the
cells during Raman analysis and to validate this approach
by capturing Raman data from DPSCs (a well characterised
pro-mineralising stromal cell population) in osteoinductive
culture. At the end point of DPSC osteogenic diﬀerentiation,
mineralised nodules can be clearly seen in the cultures and
Fig. 6 Average background subtracted spectra of osteo-induced
DPSCs at day 28 acquired from putative mineralised nodules, n = 5. The
well characterised mineral associated region at ∼955 cm−1–964 cm−1 is
clearly evident, marked *.
Fig. 7 (A) A comparison of DPSC osteogenic gene expression at day 0,
and day 28 from cells that had/had not undergone Raman spectroscopy.
Results show mean ± SE, n = 3 (day 0), n = 12 (day 28 + Raman), n = 12
(day 28 – Raman). ***p < 0.001, *p < 0.05. Signiﬁcant increases in the
expression of both genes was found between days 0 and 28 and there
was no diﬀerence in the expression between DPSCs that had and had
not undergone Raman spectroscopy. Alizarin red staining of DPSCs after
28 days of osteo-induction that (B) had undergone Raman measure-
ments and (C) had not undergone Raman measurements. Scale bars =
100 µm. Positive staining of mineralised nodules was observed regard-
less of whether the DPSCs had undergone Raman spectroscopy or not.
Fig. 8 A comparison of DPSC cell stress marker expression at day 0,
and day 28 from cells that had/had not undergone Raman spectroscopy.
Results show mean ± SE, n = 3 (day 0), 12 (day 28 + Raman), 12 (day 28 –
Raman). No signiﬁcant changes in gene expression were observed.
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there is no need for a non-invasive method to determine cellu-
lar diﬀerentiation status, as such nodules are clearly discern-
ible under an ordinary microscope without staining. Therefore
we focused on acquiring spectra in the first 14 days of osteo-
induction with a view to identifying spectral features that may
be associated with early stage cell diﬀerentiation.
The first aim of this study, to acquire Raman spectra repeat-
edly over time from the same cell cultures under aseptic con-
ditions, was achieved by customising standard tissue culture
flasks with quartz windows. This allowed DPSCs to be cultured
and analysed in the same vessel making the method truly non-
invasive. There was no evidence of any bacterial or fungal con-
tamination of our cultures at any point. However, in future
movements towards the clinical application of our research a
more extensive and exhaustive demonstration that the tech-
nique used is aseptic would be necessary. A lack of optimised
environmental control during spectra acquisition had the
potential to induce a cell stress response. In order to investi-
gate any cell stress the expression of heat shock transcription
factor 1 (HSF), hypoxia inducible factor 1 (HIF1) and lactate
dehydrogenase (LDH) was determined by qRT-PCR. HSF is a
transcription factor regulating the expression of several impor-
tant heat shock factor proteins including HSP70 and HSP90 28
and whilst it is primarily induced by hyperthermia it has been
shown to be activated in response to increasing temperature
following hypothermia.29 HIF1 is expressed in response to
hypoxia which at physiological levels (2–9% O2) is beneficial
and a key regulatory mechanism in several biological processes
including embryogenesis and stem cell function, however over-
expression at pathological levels (<1% O2) is associated with
several conditions including ischemia and cancer.30–32 LDH
expression is known to be stimulated by HIF1 expression and
is associated with cancer through increased anaerobic glycoly-
sis by a process termed the Warburg eﬀect.33,34 No significant
diﬀerences in the expression of all three marker genes were
found regardless of the Raman sampling process and relative
to the start of the experiment. Whilst this is not an exhaustive
interrogation of the eﬀects of performing Raman spectroscopy
on DPSCs in ambient conditions for approximately 3 h at a
time, it does indicate that any eﬀects were potentially negli-
gible. Previous studies have also demonstrated that Raman
spectroscopy and in particular exposure of cells to near infra-
red lasers with a power on the sample of up to 115 mW does
not induce cell damage.35 Finally, we determined that our
method had no eﬀect, detrimental or otherwise, on the osteo-
genic diﬀerentiation process as evidenced by no diﬀerences in
the expression of osteogenic marker genes or in Alizarin red
staining between DPSCs that had or had not undergone analy-
sis by Raman spectroscopy.
The second aim of the study, to validate our aseptic method
for cell phenotyping, was achieved using repeated Raman
measurements accompanying the osteoinduction of DPSCs
over time in culture. PCA was performed on spectra acquired
throughout the period in osteoinductive culture. The PCA
scores plot of PC1 versus PC2 demonstrated two phases in the
process hinged at approximately day 10. The loadings for PC1
and PC2 indicated that the pattern of those spectral features
indicative of proteins and lipids was similar while features
indicative of DNA and RNA had the opposite pattern but were
also similar to one another. When the loadings for PC1 and
PC2 were plotted against each other, protein associated peaks
were shown to vary the most in PC1 and therefore from days
0 to 10 while DNA/RNA associated peaks varied the most in PC2
and therefore from days 10 to 28. It is clear from the averaged
spectra at each time point that the protein associated peaks at
1453 cm−1 and 1660 cm−1 were increasing in intensity. Taken
together this suggests that in the early stages of DPSC osteo-
induction increasing protein content is the main marker. This
is in agreement with the findings of many others11,13,15 but is
the first instance where this has been demonstrated using
repeated measurements taken from the same cell cultures.
However, a firm conclusion is more diﬃcult to draw in the
case of the DNA/RNA associated peaks contributing to the
trend in PC2 due to their relatively low signal intensity in the
original spectra and the lower contribution of PC2 (12.4%) to
the variation within the data set. Schulze et al. 2010 11 found
that one of the major indicators of diﬀerentiation in embryo-
nic stem cells was the ratio of spectral peaks related to proteins
and DNA/RNA, concluding that the intensity of protein associ-
ated peaks increased in intensity whilst DNA/RNA peaks
decreased in intensity with diﬀerentiation. Whilst it is clear
from our data that the intensity of protein associated peaks
increases with time the trend is less clear with regards to DNA/
RNA. Our method however, was clearly able to confirm the
presence late stage osteogenic diﬀerentiation, when directed
toward mineralised nodules as evidenced by the prominent
mineral associated region at 955–964 cm−1.
Conclusions
In order to enhance the translation of stem cell based thera-
pies into the clinic, methods that permit the non-invasive
characterisation of stem cell cultures prior to their end point
are required. Our method, involving the use of standard cell
culture flasks customised with quartz windows to permit ana-
lysis by Raman spectroscopy is simple, easily reproducible and
capable of detecting events that accompany the ultimate osteo-
genic diﬀerentiation of DPSCs. This approach is easily scaled
and capable of producing large numbers of Raman-character-
ised clinically relevant cells. The sampling period in this study
was approximately 3 hours per time point/sample to produce
15 spectra for PCA; if the process of acquiring spectra was
automated an investigator would only need to prepare the
samples. Similarly PCA does not require much time to
perform. Taken together the time to perform and analyse
Raman spectroscopy would be shorter than to perform and
analyse qRT-PCR and staining on an equal number of time
points. Using destructive methods such as qRT-PCR on this
number of samples and time points would also require a
much greater number of cells and materials. As a research tool
this method can greatly reduce the time and cost associated
Analyst Paper
This journal is © The Royal Society of Chemistry 2015 Analyst, 2015, 140, 7347–7354 | 7353
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
Se
pt
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
8/
10
/2
01
5 
14
:5
9:
41
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
with producing and validating osteo-induced stem cells for use
in further research such as the production of cell seeded tissue
engineered constructs.
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